BeStock  
股票 › 生物科技 › CTMX

赛通姆治疗 CTMX

美股市值排名 #3675生物科技
$2.19 +$0.05 (+2.34%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $2.19 0.00%
开盘$2.24
昨收$2.14
当日区间$2.12 – $2.27
成交量2.73M
市值$477.43M
市盈率(TTM)–
股息率–

基本面

最新报告季度:Q2, ended Jun 2026

营收$1.42M-92.4% YoY
营业利润-$23.78M-1,749.2% YoY
净利润-$20.67M-13,319.5% YoY
摊薄每股收益-$0.09
自由现金流-$18.07M-14.5% YoY
经营现金流-$18.07M

营收,近8个季度

$33.4MSep '24$38.1MDec '24$50.9MMar '25$18.7MJun '25$6.0MSep '25$663.0KDec '25$10.3MMar '26$1.4MJun '26

净利润,近8个季度

$5.7MSep '24$18.9MDec '24$23.5MMar '25$-154.0KJun '25$-14.2MSep '25$-26.5MDec '25$-18.2MMar '26$-20.7MJun '26

各季度摊薄每股收益

0.07Sep '240.23Dec '240.27Mar '250.00Jun '25-0.09Sep '25-0.22Dec '25-0.10Mar '26-0.09Jun '26

各季度自由现金流

$-20.7MSep '24$-20.0MDec '24$-21.2MMar '25$-15.8MJun '25$-15.4MSep '25$-23.4MDec '25$-25.5MMar '26$-18.1MJun '26

年度营收

$68.4MFY20$37.3MFY21$53.2MFY22$101.2MFY23$138.1MFY24$76.2MFY25

盈利能力与资产负债表

营业利润率-476.2%
净利率-435.2%
净资产收益率-37.8%
资产收益率-28.6%
投入资本回报率-38.8%
流动比率9.36
负债/资产比率20.8%
现金及投资$330.28M
总负债$4.21M
净现金(净负债)$326.07M

利润表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
报告营业总收入 $1.42M $10.26M $76.20M $663,000.00 $5.96M
营业总收入 $1.42M $10.26M $76.20M $663,000.00 $5.96M
营业费用 $25.20M $29.93M $98.57M $28.60M $21.73M
销售及管理费用 $7.60M $10.69M $29.84M $7.36M $6.43M
-管理费用 $7.60M $10.69M $29.84M $7.36M $6.43M
研发费用 $17.60M $19.24M $68.73M $21.24M $15.30M
营业利润 -$23.78M -$19.67M -$22.36M -$27.93M -$15.77M
非经营性利息净收入(支出) $3.16M $1.49M $5.21M $1.48M $1.59M
非经营性利息收入 $3.16M $1.49M $5.21M $1.48M $1.59M
其他收入(支出) $18,000.00 -$7,000.00 $28,000.00 -$5,000.00 $5,000.00
其他非经营性收入(支出) $18,000.00 -$7,000.00 $28,000.00 -$5,000.00 $5,000.00
税前利润 -$20.61M -$18.19M -$17.13M -$26.46M -$14.17M
税费 $60,000.00 $59,000.00 $238,000.00 $54,000.00 $58,000.00
净利润 -$20.67M -$18.25M -$17.37M -$26.51M -$14.23M
持续经营利润 -$20.67M -$18.25M -$17.37M -$26.51M -$14.23M
归属母公司净利润 -$20.67M -$18.25M -$17.37M -$26.51M -$14.23M
归属普通股股东净利润 -$20.67M -$18.25M -$17.37M -$26.51M -$14.23M
基本每股收益 -$0.09 -$0.10 -$0.15 -$0.22 -$0.09
摊薄每股收益 -$0.09 -$0.10 -$0.15 -$0.22 -$0.09

资产负债表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
总资产 $381.23M $359.36M $151.57M $151.57M $158.25M
流动资产合计 $373.16M $353.10M $143.92M $143.92M $149.22M
现金及现金等价物与短期投资 $330.28M $346.71M $137.05M $137.05M $143.63M
-现金及现金等价物 $17.22M $28.83M $12.67M $12.67M $34.19M
-短期投资 $313.06M $317.88M $124.39M $124.39M $109.44M
应收款 $37.49M $646,000.00 $2.01M $2.01M $1.63M
-应收账款 $37.49M $646,000.00 $2.01M $2.01M $1.63M
受限现金 $917,000.00 – – – –
其他流动资产 $4.46M $5.74M $4.86M $4.86M $3.96M
非流动资产合计 $8.07M $6.26M $7.65M $7.65M $9.04M
固定资产净值 $6.12M $3.35M $4.70M $4.70M $6.54M
-固定资产原值 $6.12M $3.35M $21.62M $21.62M $6.54M
商誉及其他无形资产 $1.31M $1.35M $1.39M $1.39M $1.42M
-商誉 $949,000.00 $949,000.00 $949,000.00 $949,000.00 $949,000.00
-其他无形资产 $365,000.00 $401,000.00 $438,000.00 $438,000.00 $474,000.00
其他非流动资产 $641,000.00 $1.56M $1.56M $1.56M $1.08M
负债合计 $79.16M $39.41M $52.56M $52.56M $50.87M
流动负债合计 $39.86M $34.02M $46.62M $46.62M $41.03M
应付款 $1.94M $1.37M $1.30M $1.30M $646,000.00
-应付账款 $1.94M $1.37M $1.30M $1.30M $646,000.00
一年内应计费用 $12.35M $11.92M $14.20M $14.20M $12.41M
短期债务及融资租赁负债 $1.50M $2.86M $4.24M $4.24M $5.60M
-一年内到期融资租赁负债 $1.50M $2.86M $4.24M $4.24M $5.60M
一年内递延负债 $24.07M $17.88M $26.88M $26.88M $22.38M
非流动负债合计 $39.30M $5.39M $5.94M $5.94M $9.84M
长期债务及融资租赁负债 $4.21M – $0.00 $0.00 $0.00
-长期融资租赁负债 $4.21M – $0.00 $0.00 $0.00
一年以上递延负债 $30.62M $979,000.00 $1.59M $1.59M $5.54M
其他非流动负债 $4.47M $4.41M $4.35M $4.35M $4.30M
股东权益合计 $302.07M $319.94M $99.01M $99.01M $107.39M
股东权益 $302.07M $319.94M $99.01M $99.01M $107.39M
股本 $2,000.00 $2,000.00 $2,000.00 $2,000.00 $2,000.00
-普通股 $2,000.00 $2,000.00 $2,000.00 $2,000.00 $2,000.00
-优先股 $0.00 $0.00 $0.00 $0.00 $0.00
资本公积 $1.05B $1.05B $810.84M $810.84M $789.72M
留存收益 -$750.86M -$730.20M -$711.95M -$711.95M -$682.44M
不影响留存收益的损益 -$196,000.00 $102,000.00 $111,000.00 $111,000.00 $104,000.00
-累计折旧 – – -$16.92M -$16.92M –

现金流量表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
经营活动现金流 -$18.07M -$25.55M -$75.59M -$23.24M -$15.55M
持续经营经营活动现金流净额 -$18.07M -$25.55M -$75.59M -$23.24M -$15.55M
持续经营净利润 -$20.67M -$18.25M -$17.37M -$26.51M -$14.23M
折旧、折耗与摊销 $47,000.00 $251,000.00 $1.38M $510,000.00 $134,000.00
其他非现金项目 $1.37M $1.13M $4.48M $1.16M $1.13M
营运资金变动 $37,000.00 -$12.66M -$68.58M $434,000.00 -$3.33M
-应收款变动 -$36.85M $1.37M $1.09M -$384,000.00 $240,000.00
-预付资产变动 -$2.86M -$887,000.00 -$1.24M -$874,000.00 $708,000.00
-应付账款及应计费用变动 $3.91M -$3.53M -$2.83M $1.14M $93,000.00
-其他营运资金变动 $35.84M -$9.61M -$65.60M $551,000.00 -$4.38M
投资活动现金流净额 $5.95M -$192.78M -$59.74M -$14.42M $439,000.00
持续经营投资活动现金流净额 $5.95M -$192.78M -$59.74M -$14.42M $439,000.00
固定资产购置及出售净额 $0.00 $0.00 -$220,000.00 -$201,000.00 $127,000.00
投资购置及出售净额 $5.95M -$192.78M -$59.52M -$14.22M $312,000.00
筹资活动现金流 $511,000.00 $234.49M $110.45M $16.64M $253,000.00
持续经营筹资活动现金流净额 $511,000.00 $234.49M $110.45M $16.64M $253,000.00
普通股发行净额 $56,000.00 $228.35M $109.64M $16.26M $0.00
股票期权行使所得 $455,000.00 $6.14M $811,000.00 $381,000.00 $253,000.00
期末现金余额 $18.75M $30.36M $14.19M $14.19M $35.21M
现金净变动 -$11.60M $16.16M -$24.89M -$21.02M -$14.86M
期初现金余额 $30.36M $14.19M $39.08M $35.21M $50.07M
自由现金流 -$18.07M -$25.55M -$75.81M -$23.44M -$15.42M

讨论区

暂无评论——快来第一个聊聊 CTMX。

发表评论

Scroll to Top